Christian Seitz — Endo Lab

rct 2010

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

Human Reproduction ·doi:10.1093/humrep/dep469

BACKGROUND: Dienogest is a selective progestin that has been investigated in a clinical trial programme for the treatment of endometriosis. The current non-inferiority trial compared the efficacy and safety of dienogest against leuprolide a…

rct 2009

A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis

International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2009.08.020

OBJECTIVES: To compare the efficacy and safety of dienogest at doses of 1, 2, and 4mg/day orally in the treatment of endometriosis. METHODS: An open-label, randomized, multicenter, 24-week comparative trial in women with histologically con…

2009

O301 Safety of dienogest for the treatment of endometriosis: A 24‐week, randomised, open‐label trial versus leuprolide acetate

·doi:10.1016/s0020-7292(09)60673-1

2009

O341 Minimally clinically important difference for endometriosis associated pelvic pain measured on a visual analogue scale

·doi:10.1016/s0020-7292(09)60713-x

2009

O835 Long‐term experience with dienogest for the treatment of endometriosis: a one‐year, open‐label, follow‐up study

·doi:10.1016/s0020-7292(09)61208-x

other 2009

Pharmaceutical preparation for the alleviation of endometriosis

A pharmaceutical composition for the treatment of endometriosis without loss of bone density comprises a gestagenic having an antiandrogenic effect, preferably 17a-cyanomethyl-17ss-hydroxy-estra-4,9-diene-3-one (Dienogest), cyproteronacetat…

2009

PIH28 VALIDATION OF THE SF—36 IN PATIENTS WITH ENDOMETRIOSIS

·doi:10.1016/s1098-3015(10)74448-x

2009

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

·doi:10.1016/j.fertnstert.2009.07.1085

2008

A double-blind placebo-controlled trial investigating the efficacy of 12 weeks of dienogest 2 mg/day for the treatment of endometriosis-associated pain

·doi:10.1016/j.fertnstert.2008.07.230